Synthesis of fluorescent-maghemite nanoparticles as multimodal imaging agents for amyloid-β fibrils detection and removal by a magnetic field

Biochemical and Biophysical Research Communications

Volumn 386, Issue 4, 2009, Pages 645-649

  Skaat, Hadas ^a   Margel, Shlomo ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

Amyloid peptide; Fluorescent probe; Magnetic iron oxide nanoparticles; Neurodegenerative diseases; Protein folding

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; FERRIC OXIDE; NANOPARTICLE;

ALZHEIMER DISEASE; AQUEOUS SOLUTION; ARTICLE; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; MAGNETIC FIELD; MOLECULAR PROBE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; FERRIC COMPOUNDS; FLUORESCENCE; FLUORESCENT DYES; HUMANS; MAGNETICS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; PEPTIDE FRAGMENTS;

EID: 67650492226     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.06.110     Document Type: Article

References (39)

1. Selkoe D.J. Folding proteins in fatal ways. Nature 426 (2003) 900-904
2. Sunde M., and Blake C.C. From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Q. Rev. Biophys. 31 (1998) 1-39
3. Bouchard M., Zurdo J., Nettleton E.J., Dobson C.M., and Robinson C.V. Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci. 9 (2000) 1960-1967
4. Klunk W.E., Debnath M.L., Koros A.M.C., and Pettegrew J.W. Chrysamine-G, a lipophilic analogue of Congo red, inhibits a beta-induced toxicity in PC12 cells. Life Sci. 63 (1998) 1807-1814
5. Klunk W.E., Wang Y.M., Huang G.F., Debnath M.L., Holt D.P., and Mathis C.A. Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci. 69 (2001) 1471-1484
6. Sethuraman A., Vedantham G., Imoto T., Przybycien T., and Belfort G. Protein unfolding at interfaces: slow dynamics of alpha-helix to beta-sheet transition. Proteins Struct. Funct. Bioinform. 56 (2004) 669-678
7. Sethuraman A., and Belfort G. Protein structural perturbation and aggregation on homogeneous surfaces. Biophys. J. 88 (2005) 1322-1333
8. Link C.D., Johnson C.J., Fonte V., Paupard M.C., Hall D.H., Styren S., Mathis C.A., and Klunk W.E. Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. Neurobiol. Aging 22 (2001) 217-226
9. Masters C.L., Simms G., Weinman N.A., Multhaup G., Mcdonald B.L., and Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82 (1985) 4245-4249
10. Haass C., Schlossmacher M.G., Hung A.Y., Vigopelfrey C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., and Selkoe D.J. Amyloid beta-peptide is produced by cultured-cells during normal metabolism. Nature 359 (1992) 322-325
11. Seubert P., Vigopelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., Mccormack R., Wolfert R., Selkoe D., Lieberburg I., and Schenk D. Isolation and quantification of soluble Alzheimers beta-peptide from biological-fluids. Nature 359 (1992) 325-327
12. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001) 741-766
13. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75 (2006) 333-366
14. Lansbury P.T., and Lashuel H.A. A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 443 (2006) 774-779
15. Kogan M.J., Olmedo I., Hosta L., Guerrero A.R., Cruz L.J., and Albericio F. Peptides and metallic nanoparticles for biomedical applications. Nanomedicine 2 (2007) 287-306
16. De la Fuente J., and Berry C.C. Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. Bioconjug. Chem. 16 (2005) 1176-1180
17. De Vries I.J.M., Lesterhuis W.J., Barentsz J.O., Verdijk P., van Krieken J.H., Boerman O.C., Oyen W.J.G., Bonenkamp J.J., Boezeman J.B., Adema G.J., Bulte J.W.M., Scheenen T.W.J., Punt C.J.A., Heerschap A., and Figdor C.G. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 23 (2005) 1407-1413
18. Hergt R., Hiergeist R., Hilger I., Kaiser W.A., Lapatnikov Y., Margel S., and Richter U. Maghemite nanoparticles with very high AC-losses for application in RF-magnetic hyperthermia. J. Magn. Magn. Mater. 270 (2004) 345-357
19. Scherer F., Anton M., Schillinger U., Henkel J., Bergemann C., Kruger A., Gansbacher B., and Plank C. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 9 (2002) 102-109
20. Rudge S.R., Kurtz T.L., Vessely C.R., Catterall L.G., and Williamson D.L. Preparation, characterization, and performance of magnetic iron-carbon composite microparticles for chemotherapy. Biomaterials 21 (2000) 1411-1420
21. S. Margel, S. Gura, Nucleation and growth magnetic metal oxide nanoparticles and its use, EC1088315 (2003), Israel 139638, 2006.
22. Skaat H., Sorci M., Georges B., and Margel S. Effect of maghemite nanoparticles on insulin amyloid fibril formation: selective labeling, kinetics, and fibril removal by a magnetic field. J. Biomed. Mat. Res. A (2008) 10.1002/jbm.a.32232
23. Ziv O., Avtailion R., and Margel S. Acquired and natural immuginicity of gelatin, dextran and human serum albumin conjugated to magnetite nanoparticles. J. Biomed. Mat. Res. A 85 (2008) 1011-1021
24. S. Margel, T. Tennenbaum, S. Gura, M. Tsubery, Lab Tech Biochem Mol Biol Ed, Maciej Zborowski, Elsevier B.V., Amsterdam, The Netherlands, 2007.
25. Shi X., Wang S.H., Swanson S.D., Ge S., Cao Z., Van Antwerp M.E., Lanmark K.J., and Baker J.R. Dendrimer-functionalized shell-crosslinked iron oxide nanoparticles for in vivo magnetic resonance imaging of tumors. Adv. Mater. 20 (2008) 1671-1678
26. Niedre M., and Ntziachristos V. Elucidating structure and function in vivo with hybrid fluorescence and magnetic resonance imaging. Proc. IEEE 96 (2008) 382-396
27. Corr S.A., Rakovich Y.P., and Gun'ko Y.K. Multifunctional magnetic-fluorescent nanocomposites for biomedical applications. Nanoscale Res. Lett. 3 (2008) 87-104
28. Perlstein B., Ram Z., Daniels D., Ocherashvilli A., Roth Y., Margel S., and Mardor Y. Convection-enhanced delivery of maghemite nanoparticles: increased efficacy and MRI monitoring. Neurooncology 10 (2008) 153-161
29. Yang J., Lim E.K., Lee H.J., Park J., Lee S.C., Lee K., Yoon H.G., Suh J.S., Huh Y.M., and Haam S. Fluorescent magnetic nanohybrids as multimodal imaging agents for human epithelial cancer detection. Biomaterials 29 (2008) 2548-2555
30. Quarta A., Corato R.D., Manna L., Ragusa A.A.R.A., and Pellegrino T.A.P.T. Fluorescent-magnetic hybrid nanostructures: preparation, properties, and applications in biology. IEEE Trans. 6 (2007) 298-308
31. Kung H.F. Imaging of Aβ plaques in the brain of Alzheimer's disease. ICS 1264 (2004) 3-9
32. Mathis C.A., Lopresti B.J., and Klunk W.E. Impact of amyloid imaging on drug development in Alzheimer's disease. Nucl. Med. Biol. 34 (2007) 809-822
33. Sair H.I., Doraiswamy P.M., and Petrella J.R. In vivo amyloid imaging in Alzheimer's disease. Neuroradiology 46 (2004) 93-104
34. Skaat H., and Margel S. Synthesis and characterization of fluorinated magnetic core-shell nanoparticles for inhibition of insulin amyloid fibril formation. Nanotechnology 20 (2009) 225106
35. B. Perlstein, T. Lublin-tennenbaum, I. Marom, S. Margel, Synthesis and characterization of functional magnetic nanoparticles with fluorescent probe capabilities for biological applications, J. Biomed. Mat. Res. B, submitted for publication
36. Chen S., and Wetzel R. Solubilization and disaggregation of polyglutamine peptides. Protein Sci. 10 (2001) 887-891
37. Levine H. Thioflavine T interaction with amyloid β-sheet structures. Amyloid 2 (1995) 1-6
38. Liang G., Xu K., Li L., Wang L., Kuang Y., Yang Z., and Xu B. Using Congo red to report intracellular hydrogelation resulted from self-assembly of small molecules. Chem. Commun. 40 (2007) 4096-4098
39. Frid P., Anisimov S.V., and Popovic N. Congo red and protein aggregation in neurodegenerative diseases. Brain Res. Rev. 53 (2007) 135-160